Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
about
Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesEvolving New Strategies for the Medical Management of Chronic Hepatitis B Virus Infection.Treatment of hepatitis B virus: an update.Novel targets for hepatitis B virus therapy.New antivirals for the treatment of chronic hepatitis B.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection.Analysis of immunological mechanisms exerted by HBsAg-HBIG therapeutic vaccine combined with Adefovir in chronic hepatitis B patients.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.Recent advances in managing hepatitis DMacromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses.Hepatitis B cure: From discovery to regulatory approval.Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?Nucleic acid polymer REP 2139 and nucleos(t)ide analogues act synergistically against chronic hepadnaviral infection in vivo.Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
P2860
Q33821878-04D45E1C-0981-4C4C-A2FD-1A49A5E552A6Q37540212-66CC902D-9DB3-4B8D-AB58-C8E367B545C8Q38794446-42565EDB-47F3-46F0-89F5-BFDCC4D2E685Q39067316-A0B8303D-BDD8-4036-ABAE-376E6B762C46Q39315990-14BDC0E5-122A-40FD-A899-919A0E1622ECQ39414876-09B40F15-2B4F-4B8F-B2C1-0774E26E0919Q39425755-0C177E82-CC21-44FF-8D45-D74219D4ED7DQ40130098-5EA6ADF0-26B8-4E4F-9A1E-FA5A4EA363A3Q40139678-41F83AB7-DC42-4DF7-B53A-E19DC38E9826Q40302798-367BA7D1-A71D-4268-8922-8D4707673383Q41588940-C1820CBB-7B60-44E5-B80F-CDFE9F06D385Q41930666-223FABD3-C830-4F3C-BD4B-B14F033A4C36Q41952398-7D7A0031-49DC-44F2-ACF3-C8173FDBA922Q42209643-D065D4BF-7C1D-461E-9023-33E42E8DE56EQ45323707-AB2BB74D-8E3D-49BC-AA63-17250C8CC494Q46263692-5F76EBD3-E4DF-416F-BA37-EAC3FBD91F72Q47136128-4E6FDF6D-4D72-4D8B-A1F6-260A47533862Q47564306-E5F5A745-B9C3-4312-A9A0-86D3207811A5Q58759982-76AD1234-4BDF-4F47-869D-F4C84CF5C0E7
P2860
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@ast
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@en
type
label
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@ast
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@en
prefLabel
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@ast
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@en
P2093
P2860
P1433
P1476
Safety and Efficacy of Nucleic ...... Chronic Hepatitis B Infection
@en
P2093
Andrew Vaillant
Mamun Al-Mahtab
Michel Bazinet
P2860
P304
P356
10.1371/JOURNAL.PONE.0156667
P407
P577
2016-06-03T00:00:00Z